Of all the cancers that affect dogs, mammary gland tumours are among the most common. And yet they are also among the most frequently missed in their early stages.
A small lump along a female dog’s belly is easy to overlook. Easy to attribute to a cyst or a minor skin change. Easy to decide to watch for a few more weeks before doing anything about it.
That delay is where the problem begins.
Mammary tumours in dogs develop in the milk-producing glands that run along the chest and abdomen in two parallel chains from the chest to the groin. Roughly half of all mammary tumours in dogs are malignant. And malignant mammary tumours, when caught early, are among the most treatable cancers in veterinary medicine. When caught late, they are among the most destructive.
The difference between those two outcomes is often nothing more than how quickly an owner noticed a lump and acted on it.
This guide explains what mammary gland tumours are, how to recognise them, and what treatment and outcomes look like for affected dogs. For guidance on recognising early warning signs of cancer across multiple body systems, the resource on subtle signs of cancer in pets is essential reading for every dog owner.
What Are Mammary Gland Tumours in Dogs?
Mammary gland tumours develop when cells within the mammary tissue undergo abnormal growth and form a mass. Dogs have five pairs of mammary glands, ten in total, running in two lines from the chest to the lower abdomen. Any of these glands can develop a tumour, and it is not uncommon for multiple glands to be affected simultaneously or sequentially.
Approximately fifty percent of mammary tumours in dogs are benign, and approximately fifty percent are malignant. This near-equal split is what makes diagnosis so important. A lump that looks and feels identical to a benign one externally may be malignant internally. Visual and tactile assessment by an owner, or even a general veterinary examination, cannot reliably distinguish the two. Only laboratory analysis of the tissue can confirm it.
Malignant mammary tumours vary in how aggressively they behave. Some grow slowly and metastasise late. Others are highly aggressive, spreading to lymph nodes and distant organs within a short period. The type and grade of the tumour, determined through biopsy, is what tells the veterinary team what they are dealing with and how urgently treatment is needed.
Prevalence of Mammary Tumours in Dogs
Mammary tumours account for a substantial portion of all tumours diagnosed in female dogs. In intact, unspayed female dogs, they represent over forty percent of all tumour diagnoses, making them the single most common tumour type in this population.
The contrast with spayed female dogs is stark. Dogs spayed before their first heat cycle have a dramatically reduced lifetime risk of mammary tumours, with some studies placing the reduction at over ninety-nine percent compared to intact females. Dogs spayed after one heat cycle retain some elevated risk, and dogs spayed after two or more heat cycles have a significantly higher risk that approaches that of intact females.
This data is one of the strongest arguments for early spaying in female dogs not intended for breeding. It is not a minor statistical difference. It is a near-complete prevention of one of the most common canine cancers.
Most mammary tumours are diagnosed in dogs between six and ten years of age, with the peak incidence around nine to ten years. They are rare in dogs under two years old, regardless of spay status.
Symptoms of Mammary Tumours in Dogs
The earliest and most important symptom is a lump. But the characteristics of that lump, and what surrounds it, provide important additional information.
A mass along the mammary chain. The most posterior mammary glands, those closest to the groin, are affected more frequently than the others. Any new lump felt along the line of mammary glands, whether in the skin, beneath it, or attached to the gland itself, deserves prompt veterinary evaluation.
Variable size and texture. Early tumours may be small, firm, and clearly defined. Others are softer, less well-defined, or feel attached to the underlying tissue. As tumours grow, they can become large, irregular, and fixed to surrounding structures.
Ulceration of the skin over the lump. When tumours grow faster than the overlying skin can accommodate, the skin breaks down. Open sores over a mammary lump that do not heal are a serious sign requiring immediate veterinary assessment.
Nipple discharge. Bloody, cloudy, or unusual discharge from a nipple not associated with nursing can indicate a tumour affecting the glandular tissue.
Swelling extending beyond the lump. In inflammatory mammary carcinoma, one of the most aggressive forms, the entire mammary chain or a significant portion of it becomes swollen, hot, and painful. This presentation can resemble a severe infection, which is one reason it is sometimes initially misdiagnosed.
Lethargy and reduced appetite. In more advanced cases, systemic effects of the cancer become apparent. A dog that is less energetic, eating less, or losing weight alongside a mammary mass should be assessed urgently.
Swollen lymph nodes. The lymph nodes in the groin and armpit are the primary drainage sites for the mammary glands. Swelling in these areas alongside a mammary lump suggests the cancer may have begun to spread regionally. Knowing the subtle signs of cancer in pets that often precede obvious symptoms can help owners act before the disease advances.
Related Videos
Causes and Risk Factors
The most important and best-established cause of mammary tumours in dogs is hormonal exposure.
Oestrogen and progesterone drive the development and function of mammary gland tissue throughout a dog’s reproductive life. Prolonged exposure to these hormones, through repeated heat cycles, creates conditions in which the glandular cells are repeatedly stimulated to grow and divide. Over time, this increases the probability of malignant transformation.
Intact status is the single greatest risk factor. Unspayed female dogs face a dramatically elevated lifetime risk of mammary tumours compared to spayed females, particularly those spayed early in life.
Age is a consistent factor. The risk increases with each passing year and is highest in middle-aged to older dogs.
Obesity has been associated with elevated mammary tumour risk in some studies, possibly because adipose tissue produces oestrogen independently of the ovaries.
Breed predisposition has been noted, with Poodles, Dachshunds, Cocker Spaniels, and certain terrier breeds showing higher rates of mammary tumours compared to the general female dog population.
Use of hormonal medications. Dogs that have received progestins or oestrogens, sometimes prescribed to prevent heat cycles or for other reproductive management purposes, have an elevated risk of mammary tumour development. This is an important consideration when discussing long-term reproductive management with your veterinarian.
Types of Mammary Tumours in Dogs
Mammary tumours encompass a spectrum of growth types with very different clinical implications.
Benign tumours include simple adenomas, complex adenomas, and fibroadenomas. These grow slowly, remain localised, and do not spread to other parts of the body. Surgical removal is typically curative.
Malignant tumours include simple carcinomas, complex carcinomas, and the rarer but highly aggressive sarcomas. Carcinomas are by far the most common malignant type. They vary in grade from low, where cells are relatively well-organised and spread slowly, to high, where cells are poorly differentiated and aggressive.
Inflammatory mammary carcinoma is the most aggressive form and requires specific recognition. It presents as rapid, diffuse swelling, redness, heat, and pain across the mammary chain and is often initially mistaken for mastitis or a bacterial infection. It spreads rapidly through the lymphatic system and carries a poor prognosis. Treatment with antibiotics alone will not resolve it, and a delay in identifying it as cancer worsens outcomes significantly.
Mixed mammary tumours contain both glandular and connective tissue components. Their behaviour depends on whether a malignant component is present.
The histological type and grade are determined by biopsy and are essential to treatment planning and prognosis.
How Veterinarians Diagnose Mammary Cancer
Diagnosis requires more than identifying a lump. It requires understanding what the lump is made of and whether it has spread.
Physical examination. The veterinarian will assess every mammary gland systematically, noting the number, size, location, and characteristics of all lumps. Regional lymph nodes are palpated for enlargement.
Fine needle aspiration. A thin needle is used to collect cells from the mass. Cytological examination of these cells can provide initial information about the nature of the tumour, though it does not always yield a definitive diagnosis for mammary tumours specifically.
Biopsy and histopathology. Surgical biopsy provides the definitive diagnosis. In many cases, the entire tumour is submitted for histopathology following surgical removal. The pathologist confirms whether the tumour is benign or malignant, identifies the specific type, assesses the margins, and grades the malignancy. This information directly shapes post-operative treatment decisions.
Chest X-rays. Assessing the lungs for metastatic nodules is a critical part of staging. Lung metastasis significantly changes the prognosis and may alter the treatment approach.
Abdominal ultrasound. This evaluates the regional lymph nodes and abdominal organs for signs of spread.
Blood tests. A full panel assesses overall health and organ function, guiding anaesthetic and treatment decisions. For further guidance on monitoring overall canine health and recognising early abnormalities, the Vet Advice for Dog Health resource provides practical, clinically grounded information.
Treatment Options for Mammary Tumours
Surgery is the cornerstone of treatment for mammary tumours in dogs, and in many cases, it is the only treatment required.
Surgical removal options range from lumpectomy, removing only the individual tumour with a margin of surrounding tissue, to regional or radical mastectomy, removing the entire affected mammary chain and associated lymph nodes. The extent of surgery is determined by the number and distribution of tumours, their characteristics, and the veterinarian’s assessment of what is needed to achieve clean margins.
Complete surgical removal with histologically confirmed clean margins is the goal. When this is achieved for a localised, low-grade tumour, surgery alone is often curative.
Concurrent spaying. If the dog is intact, spaying at the time of tumour surgery removes the hormonal drive that contributed to the tumour’s development and reduces the risk of new tumours forming in the remaining mammary tissue.
Chemotherapy is recommended when the tumour is high-grade, when lymph node involvement is confirmed, or when complete surgical removal was not achieved. Doxorubicin-based protocols are most commonly used for malignant mammary carcinomas.
Radiation therapy may be considered in selected cases where complete surgical excision is not possible or where local recurrence has occurred.
Management of inflammatory mammary carcinoma. This aggressive form does not typically respond well to surgery alone. Chemotherapy is the primary approach, though prognosis remains poor even with treatment. Early recognition of this specific presentation is critical.
Prognosis and Survival Rate
Prognosis for mammary tumours in dogs is highly variable and directly tied to the stage and type of disease at diagnosis.
For small, well-defined, completely excised benign tumours, the prognosis is excellent. Surgical removal is curative, and recurrence is uncommon.
For malignant tumours caught early, before lymph node or distant metastasis, complete surgical excision with clean margins provides a meaningful chance of long-term remission. Median survival times of over two years are reported for dogs with low-grade malignant tumours treated with complete excision.
For malignant tumours with lymph node involvement, prognosis is more guarded,d but treatment can still extend survival significantly. Dogs with regional metastasis treated with surgery and chemotherapy can live six to twelve months or longer with a maintained quality of life.
For inflammatory mammary carcinoma or tumours with distant metastasis at diagnosis, prognosis is poor, with survival typically measured in weeks to months. Palliative care to maintain comfort becomes the priority.
The consistent pattern across all mammary tumour outcomes is this: the earlier the diagnosis, the better the outcome. A tumour found at one centimetre offers far more options than one found at five.
Complications of Untreated Mammary Tumours
Choosing to watch and wait with a mammary lump, without veterinary assessment and a clear plan, carries real and escalating risks.
Metastasis to the lungs. The lungs are the most common site of distant spread for malignant mammary tumours. Once lung metastasis is confirmed, the treatment landscape narrows dramatically.
Lymph node spread. Regional metastasis to the groin or axillary lymph nodes indicates the cancer has access to the lymphatic system and is no longer purely localised.
Ulceration and infection. Growing tumours break through the skin surface, creating open wounds that are painful, vulnerable to bacterial infection, and a source of significant ongoing discomfort.
Spread to the liver, spleen, and bone. Advanced malignant tumours can spread to multiple organs simultaneously, causing systemic illness, organ dysfunction, and significant deterioration in overall condition.
Inflammatory carcinoma progression. If inflammatory mammary carcinoma is not identified and treated promptly, it progresses with alarming speed. The diffuse lymphatic spread characteristic of this form makes delayed treatment particularly consequential.
Can Mammary Tumours Be Prevented?
Yes. This is one of the few canine cancers where a single preventive action has a profound and well-documented impact.
Spaying before the first heat cycle reduces a female dog’s lifetime risk of mammary tumours by more than ninety-nine percent in some studies. The protective effect is powerful and clear.
Spaying after the first heat still provides significant protection compared to remaining intact, but the effect diminishes with each subsequent heat cycle. By the time a dog has had two or more heat cycles, the protective value of spaying against mammary tumour risk is considerably reduced.
For any female dog not intended for breeding, discussing the timing of spaying with your veterinarian is one of the most important health conversations you will have. The mammary tumour data alone make early spaying a compelling choice from a cancer prevention perspective.
Beyond spaying, maintaining a healthy body weight and avoiding unnecessary hormonal medications reduces risk further, though these factors are secondary to spay status in their overall impact.
When Should You See a Veterinarian?
Any new lump discovered along a female dog’s mammary chain warrants a veterinary appointment. Not eventually. Soon.
This is true regardless of how small the lump is, whether it appears to cause any discomfort, and whether your dog is otherwise healthy and eating well. Mammary tumours do not announce their malignancy through pain or obvious illness in their early stages. The only way to know what a lump is is to have it assessed.
See your veterinarian urgently, meaning within twenty-four to forty-eight hours, if the lump is growing rapidly, if the skin over it has broken down, if there is nipple discharge, if the mammary area is swollen, hot, and painful across a wide area, or if your dog shows signs of systemic illness alongside the lump.
Early Detection Saves Lives
Mammary tumours are one of the most common cancers in female dogs. They are also one of the most treatable when found early.
That equation, common but treatable when caught early, makes regular physical checks of your female dog’s mammary chain one of the most important habits you can build as an owner. Once a month, run your hands along both rows of glands from chest to groin. Feel for anything new. Note it. Act on it.
The dogs that do best with mammary tumours are not the ones with less aggressive cancers. They are the ones whose owners found something small and went to the vet the same week.
For comprehensive guidance on maintaining your dog’s health and recognising early warning signs across a range of conditions, VOSD provides detailed, veterinary-grounded resources built from years of frontline canine care experience. The guide to subtle signs of cancer in pets is a practical starting point for every owner who wants to stay ahead of their dog’s health.
